Unique Formulation Capabilities

Our ImplaVax® platform is built upon our advanced formulation capabilities, evidenced by the breadth of UVIs made to date and their applicability to all current vaccine formats, including sub-units, toxoids, conjugates, peptides, proteins, virus-like particles, recombinant products, live attenuated viruses, vector-based systems, and DNA-based vaccines.

Current projects include but are not limited to Influenza, measles-Rubella, HPV, HIV, Shigella, Anti-microbial resistance, TCV, and a number of emergent threat pathogens and Medical Counter Measures.

Unique Formulation Capabilities